These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 20536841)
1. Molecular bridging of aging and cancer: A CARF link. Cheung CT; Kaul SC; Wadhwa R Ann N Y Acad Sci; 2010 Jun; 1197():129-33. PubMed ID: 20536841 [TBL] [Abstract][Full Text] [Related]
2. CARF binds to three members (ARF, p53, and HDM2) of the p53 tumor-suppressor pathway. Kamrul HM; Wadhwa R; Kaul SC Ann N Y Acad Sci; 2007 Apr; 1100():312-5. PubMed ID: 17460193 [TBL] [Abstract][Full Text] [Related]
3. CARF (collaborator of ARF) interacts with HDM2: evidence for a novel regulatory feedback regulation of CARF-p53-HDM2-p21WAF1 pathway. Hasan MK; Yaguchi T; Harada JI; Hirano T; Wadhwa R; Kaul SC Int J Oncol; 2008 Mar; 32(3):663-71. PubMed ID: 18292944 [TBL] [Abstract][Full Text] [Related]
4. CARF is a multi-module regulator of cell proliferation and a molecular bridge between cellular senescence and carcinogenesis. Wadhwa R; Kalra RS; Kaul SC Mech Ageing Dev; 2017 Sep; 166():64-68. PubMed ID: 28754531 [TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of collaborator of ARF (CARF) as a DNA damage response and cell cycle checkpoint regulatory protein. Singh R; Kalra RS; Hasan K; Kaul Z; Cheung CT; Huschtscha L; Reddel RR; Kaul SC; Wadhwa R Exp Cell Res; 2014 Apr; 322(2):324-34. PubMed ID: 24485912 [TBL] [Abstract][Full Text] [Related]
7. CARF Is a vital dual regulator of cellular senescence and apoptosis. Hasan K; Cheung C; Kaul Z; Shah N; Sakaushi S; Sugimoto K; Oka S; Kaul SC; Wadhwa R J Biol Chem; 2009 Jan; 284(3):1664-72. PubMed ID: 19001376 [TBL] [Abstract][Full Text] [Related]
8. Collaborator of ARF (CARF) regulates proliferative fate of human cells by dose-dependent regulation of DNA damage signaling. Cheung CT; Singh R; Kalra RS; Kaul SC; Wadhwa R J Biol Chem; 2014 Jun; 289(26):18258-69. PubMed ID: 24825908 [TBL] [Abstract][Full Text] [Related]
9. Alternative reading frame protein (ARF)-independent function of CARF (collaborator of ARF) involves its interactions with p53: evidence for a novel p53-activation pathway and its negative feedback control. Hasan MK; Yaguchi T; Minoda Y; Hirano T; Taira K; Wadhwa R; Kaul SC Biochem J; 2004 Jun; 380(Pt 3):605-10. PubMed ID: 15109303 [TBL] [Abstract][Full Text] [Related]
10. CARF: an emerging regulator of p53 tumor suppressor and senescence pathway. Cheung CT; Hasan MK; Widodo N; Kaul SC; Wadhwa R Mech Ageing Dev; 2009; 130(1-2):18-23. PubMed ID: 18555516 [TBL] [Abstract][Full Text] [Related]
11. CARF regulates p19ARF-p53-p21WAF1 senescence pathway by multiple checkpoints. Kaul SC; Hasan K; Wadhwa R Ann N Y Acad Sci; 2006 May; 1067():217-9. PubMed ID: 16803988 [TBL] [Abstract][Full Text] [Related]
12. CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53. Hasan MK; Yaguchi T; Sugihara T; Kumar PK; Taira K; Reddel RR; Kaul SC; Wadhwa R J Biol Chem; 2002 Oct; 277(40):37765-70. PubMed ID: 12154087 [TBL] [Abstract][Full Text] [Related]
13. Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways. Weber HO; Samuel T; Rauch P; Funk JO Oncogene; 2002 May; 21(20):3207-12. PubMed ID: 12082636 [TBL] [Abstract][Full Text] [Related]
14. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence. Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633 [TBL] [Abstract][Full Text] [Related]
15. Evidence that proteasome-dependent degradation of the retinoblastoma protein in cells lacking A-type lamins occurs independently of gankyrin and MDM2. Nitta RT; Smith CL; Kennedy BK PLoS One; 2007 Sep; 2(9):e963. PubMed ID: 17896003 [TBL] [Abstract][Full Text] [Related]
16. Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin. Efeyan A; Ortega-Molina A; Velasco-Miguel S; Herranz D; Vassilev LT; Serrano M Cancer Res; 2007 Aug; 67(15):7350-7. PubMed ID: 17671205 [TBL] [Abstract][Full Text] [Related]
17. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers. Sarkar S; Jülicher KP; Burger MS; Della Valle V; Larsen CJ; Yeager TR; Grossman TB; Nickells RW; Protzel C; Jarrard DF; Reznikoff CA Cancer Res; 2000 Jul; 60(14):3862-71. PubMed ID: 10919661 [TBL] [Abstract][Full Text] [Related]
18. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53. Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969 [TBL] [Abstract][Full Text] [Related]
19. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594 [TBL] [Abstract][Full Text] [Related]
20. Dynamics of ARF regulation that control senescence and cancer. Ko A; Han SY; Song J BMB Rep; 2016 Nov; 49(11):598-606. PubMed ID: 27470213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]